Gold Daniel Allen 4

What Happened

• Daniel Allen Gold (listed as a director) reported multiple open-market sales of Roivant Sciences Ltd. (ROIV) common shares. The filing shows five disposals between 2026-06-26 and 2026-06-30 totaling 1,438,163 shares for aggregate proceeds of approximately $49.35 million. This is a sale (not a purchase), which is typically viewed as routine disposition or portfolio rebalancing rather than a bullish signal.

Key Details

• Individual transactions reported:
  • 2026-06-26: 300,783 shares @ $33.92 — $10,202,559
  • 2026-06-26: 325,000 shares @ $34.07 — $11,072,750
  • 2026-06-29: 200,000 shares @ $34.44 — $6,888,000
  • 2026-06-29: 600,000 shares @ $34.59 — $20,754,000
  • 2026-06-30: 12,380 shares @ $35.28 — $436,766
• Total sold: 1,438,163 shares for about $49,354,075.
• Shares owned after the transactions: not specified in the provided filing.
• Footnote: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. (QVT FIC) and shares voting and investment control over the Common Shares held directly by QVT FIC. The filer disclaims beneficial ownership except to the extent of pecuniary interest.
• Filing info/timeliness: Form 4 was filed on 2026-06-30 reporting transactions dated 2026-06-26 through 2026-06-30. The filing does not indicate a late reporting flag.

Context

• These are outright sales (transaction code "S") of common stock reported by an individual who also represents an institutional holder (QVT FIC). Institutional or director-led sales often reflect liquidity needs or portfolio management rather than a direct signal about company fundamentals. No options/exercises, gifts, or tax-withholding transactions are indicated in this filing.